GPT and Cirrhosis: In contrast, most patients in the HBeAg negative chronic hepatitis B (CHB) phase, which is characterized by HBeAg negativity, persistently or intermittently elevated levels of ALT, and HBV DNA levels ≥ 2,000 IU/ml, have an increased risk of cirrhosis and HCC [5].